Stroke, Vol 18, 524-527, Copyright © 1987 by American Heart Association
AB Sterman, AJ Furlan, M Pessin, C Kase, L Caplan and G Williams
We discuss selected issues concerning the design of stroke treatment
trials. Key issues include the type of stroke studied, the time interval
from stroke onset to patient entry, and whether to include cardioembolic
strokes and allow concomitant therapy.
ARTICLES
Acute stroke therapy trials: an introduction to recurring design issues
This article has been cited by other articles:
![]() |
J. A. Zivin Thrombolytic stroke therapy: Past, present, and future Neurology, July 1, 1999; 53(1): 14 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Toni, M. Fiorelli, M. Gentile, S. Bastianello, M. L. Sacchetti, C. Argentino, C. Pozzilli, and C. Fieschi Progressing Neurological Deficit Secondary to Acute Ischemic Stroke: A Study on Predictability, Pathogenesis, and Prognosis Arch Neurol, July 1, 1995; 52(7): 670 - 675. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |